

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to interferon-beta (GO:0035456) | 5.97906803 |
| 2 | eosinophil chemotaxis (GO:0048245) | 5.20963566 |
| 3 | response to interferon-alpha (GO:0035455) | 5.13421501 |
| 4 | * cellular response to type I interferon (GO:0071357) | 5.00414266 |
| 5 | * type I interferon signaling pathway (GO:0060337) | 5.00414266 |
| 6 | * response to type I interferon (GO:0034340) | 4.94594227 |
| 7 | regulation of sequestering of triglyceride (GO:0010889) | 4.74553926 |
| 8 | eosinophil migration (GO:0072677) | 4.60420599 |
| 9 | valine metabolic process (GO:0006573) | 4.58998313 |
| 10 | complement activation, classical pathway (GO:0006958) | 4.25600507 |
| 11 | fatty acid beta-oxidation (GO:0006635) | 4.17575413 |
| 12 | positive regulation of pseudopodium assembly (GO:0031274) | 3.98093043 |
| 13 | low-density lipoprotein particle clearance (GO:0034383) | 3.92575883 |
| 14 | negative regulation of viral genome replication (GO:0045071) | 3.91214710 |
| 15 | fatty acid catabolic process (GO:0009062) | 3.89223304 |
| 16 | brown fat cell differentiation (GO:0050873) | 3.87094035 |
| 17 | fatty acid oxidation (GO:0019395) | 3.80224242 |
| 18 | triglyceride catabolic process (GO:0019433) | 3.79270521 |
| 19 | complement activation (GO:0006956) | 3.77484540 |
| 20 | negative regulation of viral entry into host cell (GO:0046597) | 3.76261912 |
| 21 | lipid oxidation (GO:0034440) | 3.74682964 |
| 22 | biotin metabolic process (GO:0006768) | 3.74356417 |
| 23 | alpha-linolenic acid metabolic process (GO:0036109) | 3.72465929 |
| 24 | positive regulation of respiratory burst (GO:0060267) | 3.69381323 |
| 25 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.66778906 |
| 26 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.62483410 |
| 27 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.62483410 |
| 28 | fatty acid transmembrane transport (GO:1902001) | 3.58390324 |
| 29 | fibrinolysis (GO:0042730) | 3.57984257 |
| 30 | regulation of pseudopodium assembly (GO:0031272) | 3.53063286 |
| 31 | positive regulation of fatty acid oxidation (GO:0046321) | 3.49546430 |
| 32 | branched-chain amino acid catabolic process (GO:0009083) | 3.43766717 |
| 33 | acylglycerol catabolic process (GO:0046464) | 3.41508728 |
| 34 | neutral lipid catabolic process (GO:0046461) | 3.41508728 |
| 35 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.39916528 |
| 36 | carnitine shuttle (GO:0006853) | 3.39480893 |
| 37 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.36000660 |
| 38 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.35312480 |
| 39 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.33453327 |
| 40 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.33453327 |
| 41 | cellular response to interferon-alpha (GO:0035457) | 3.32919345 |
| 42 | immunoglobulin mediated immune response (GO:0016064) | 3.32445621 |
| 43 | regulation of cellular extravasation (GO:0002691) | 3.31776226 |
| 44 | branched-chain amino acid metabolic process (GO:0009081) | 3.30136946 |
| 45 | regulation of triglyceride catabolic process (GO:0010896) | 3.30125692 |
| 46 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.27945357 |
| 47 | morphogenesis of an endothelium (GO:0003159) | 3.27457709 |
| 48 | endothelial tube morphogenesis (GO:0061154) | 3.27457709 |
| 49 | monocarboxylic acid catabolic process (GO:0072329) | 3.26952302 |
| 50 | negative regulation of complement activation (GO:0045916) | 3.24653555 |
| 51 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.23955735 |
| 52 | regulation of fatty acid oxidation (GO:0046320) | 3.23545411 |
| 53 | regulation of viral entry into host cell (GO:0046596) | 3.23304648 |
| 54 | interferon-gamma secretion (GO:0072643) | 3.20909696 |
| 55 | cellular response to interferon-beta (GO:0035458) | 3.20024839 |
| 56 | protein activation cascade (GO:0072376) | 3.17488366 |
| 57 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.13859052 |
| 58 | regulation of mononuclear cell migration (GO:0071675) | 3.12511000 |
| 59 | acyl-CoA biosynthetic process (GO:0071616) | 3.11741503 |
| 60 | thioester biosynthetic process (GO:0035384) | 3.11741503 |
| 61 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.11173394 |
| 62 | regulation of respiratory burst (GO:0060263) | 3.06175149 |
| 63 | phenol-containing compound catabolic process (GO:0019336) | 3.05067854 |
| 64 | detection of bacterium (GO:0016045) | 3.04677797 |
| 65 | extracellular fibril organization (GO:0043206) | 3.03926736 |
| 66 | L-phenylalanine catabolic process (GO:0006559) | 3.03816518 |
| 67 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.03816518 |
| 68 | cellular response to exogenous dsRNA (GO:0071360) | 3.03177387 |
| 69 | fibril organization (GO:0097435) | 3.03105092 |
| 70 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.02090064 |
| 71 | regulation of cholesterol storage (GO:0010885) | 2.99702841 |
| 72 | regulation of protein activation cascade (GO:2000257) | 2.99260252 |
| 73 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.98931500 |
| 74 | L-phenylalanine metabolic process (GO:0006558) | 2.98931500 |
| 75 | lipid storage (GO:0019915) | 2.98477388 |
| 76 | adhesion of symbiont to host cell (GO:0044650) | 2.94837369 |
| 77 | virion attachment to host cell (GO:0019062) | 2.94837369 |
| 78 | protein maturation by protein folding (GO:0022417) | 2.94707546 |
| 79 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.93697701 |
| 80 | hormone catabolic process (GO:0042447) | 2.92824234 |
| 81 | triglyceride biosynthetic process (GO:0019432) | 2.91278280 |
| 82 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.90849488 |
| 83 | negative regulation of protein activation cascade (GO:2000258) | 2.89829288 |
| 84 | sulfur amino acid catabolic process (GO:0000098) | 2.89296203 |
| 85 | regulation of macrophage chemotaxis (GO:0010758) | 2.89149564 |
| 86 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.89055642 |
| 87 | neutral lipid biosynthetic process (GO:0046460) | 2.88826847 |
| 88 | acylglycerol biosynthetic process (GO:0046463) | 2.88826847 |
| 89 | regulation of cholesterol metabolic process (GO:0090181) | 2.87992475 |
| 90 | negative regulation of protein autophosphorylation (GO:0031953) | 2.87402453 |
| 91 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.87205550 |
| 92 | detection of other organism (GO:0098543) | 2.85886260 |
| 93 | regulation of metalloenzyme activity (GO:0048552) | 2.85771081 |
| 94 | response to interferon-gamma (GO:0034341) | 2.85563711 |
| 95 | complement activation, alternative pathway (GO:0006957) | 2.84730623 |
| 96 | short-chain fatty acid metabolic process (GO:0046459) | 2.82356904 |
| 97 | urea cycle (GO:0000050) | 2.82016071 |
| 98 | GDP-mannose metabolic process (GO:0019673) | 2.81785408 |
| 99 | positive regulation of lipid catabolic process (GO:0050996) | 2.81512793 |
| 100 | urea metabolic process (GO:0019627) | 2.80329262 |
| 101 | angiotensin maturation (GO:0002003) | 2.79877270 |
| 102 | NADH metabolic process (GO:0006734) | 2.78646621 |
| 103 | acetyl-CoA metabolic process (GO:0006084) | 2.78058486 |
| 104 | transcytosis (GO:0045056) | 2.77875706 |
| 105 | plasma lipoprotein particle clearance (GO:0034381) | 2.77518885 |
| 106 | negative regulation of humoral immune response (GO:0002921) | 2.76700797 |
| 107 | carnitine transmembrane transport (GO:1902603) | 2.76526966 |
| 108 | carnitine metabolic process (GO:0009437) | 2.76469550 |
| 109 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.74109228 |
| 110 | triglyceride metabolic process (GO:0006641) | 2.73333715 |
| 111 | lipid particle organization (GO:0034389) | 2.73284415 |
| 112 | thioester metabolic process (GO:0035383) | 2.71760187 |
| 113 | acyl-CoA metabolic process (GO:0006637) | 2.71760187 |
| 114 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.69854542 |
| 115 | epoxygenase P450 pathway (GO:0019373) | 2.69539973 |
| 116 | negative regulation of lipid storage (GO:0010888) | 2.69151270 |
| 117 | white fat cell differentiation (GO:0050872) | 2.69039211 |
| 118 | barbed-end actin filament capping (GO:0051016) | 2.68207086 |
| 119 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.68106428 |
| 120 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.67199898 |
| 121 | cellular response to interferon-gamma (GO:0071346) | 2.66493534 |
| 122 | regulation of triglyceride metabolic process (GO:0090207) | 2.66457148 |
| 123 | opsonization (GO:0008228) | 2.65680461 |
| 124 | negative regulation of viral process (GO:0048525) | 2.63856753 |
| 125 | nitrogen cycle metabolic process (GO:0071941) | 2.63053486 |
| 126 | negative regulation of lipase activity (GO:0060192) | 2.61951222 |
| 127 | arginine catabolic process (GO:0006527) | 2.61916555 |
| 128 | cellular response to virus (GO:0098586) | 2.61865611 |
| 129 | glomerular filtration (GO:0003094) | 2.60678125 |
| 130 | negative regulation of coagulation (GO:0050819) | 2.59785797 |
| 131 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.59515425 |
| 132 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.59418768 |
| 133 | positive regulation of type 2 immune response (GO:0002830) | 2.59118001 |
| 134 | negative regulation of hemostasis (GO:1900047) | 2.58729208 |
| 135 | negative regulation of blood coagulation (GO:0030195) | 2.58729208 |
| 136 | defense response to virus (GO:0051607) | 2.58402829 |
| 137 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.57903184 |
| 138 | detection of external biotic stimulus (GO:0098581) | 2.57616885 |
| 139 | adhesion of symbiont to host (GO:0044406) | 2.56666105 |
| 140 | acylglycerol metabolic process (GO:0006639) | 2.56483330 |
| 141 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.56463413 |
| 142 | arginine metabolic process (GO:0006525) | 2.56115990 |
| 143 | neutral lipid metabolic process (GO:0006638) | 2.55039630 |
| 144 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.54636848 |
| 145 | protein carboxylation (GO:0018214) | 2.53726294 |
| 146 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.53726294 |
| 147 | renal filtration (GO:0097205) | 2.53566759 |
| 148 | bile acid biosynthetic process (GO:0006699) | 2.53400809 |
| 149 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.53234513 |
| 150 | carnitine transport (GO:0015879) | 2.52124583 |
| 151 | amino-acid betaine transport (GO:0015838) | 2.52124583 |
| 152 | amino-acid betaine metabolic process (GO:0006577) | 2.51398318 |
| 153 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.50618878 |
| 154 | cellular lipid catabolic process (GO:0044242) | 2.50127978 |
| 155 | antimicrobial humoral response (GO:0019730) | 2.49602888 |
| 156 | coenzyme A metabolic process (GO:0015936) | 2.48562270 |
| 157 | drug metabolic process (GO:0017144) | 2.48478330 |
| 158 | bile acid and bile salt transport (GO:0015721) | 2.48261776 |
| 159 | lymphocyte chemotaxis (GO:0048247) | 2.47408110 |
| 160 | NADP metabolic process (GO:0006739) | 2.46895073 |
| 161 | tricarboxylic acid metabolic process (GO:0072350) | 2.45412532 |
| 162 | positive regulation of cholesterol transport (GO:0032376) | 2.45340563 |
| 163 | positive regulation of sterol transport (GO:0032373) | 2.45340563 |
| 164 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.45206652 |
| 165 | NADPH regeneration (GO:0006740) | 2.44500701 |
| 166 | regulation of RIG-I signaling pathway (GO:0039535) | 2.44339226 |
| 167 | xenobiotic catabolic process (GO:0042178) | 2.43884833 |
| 168 | peptide catabolic process (GO:0043171) | 2.43866654 |
| 169 | coenzyme catabolic process (GO:0009109) | 2.42025140 |
| 170 | succinate metabolic process (GO:0006105) | 2.41998164 |
| 171 | ethanol oxidation (GO:0006069) | 2.41384751 |
| 172 | cofactor catabolic process (GO:0051187) | 2.41203197 |
| 173 | cellular copper ion homeostasis (GO:0006878) | 2.40555058 |
| 174 | humoral immune response (GO:0006959) | 2.39892615 |
| 175 | regulation of viral genome replication (GO:0045069) | 2.39435679 |
| 176 | coenzyme A biosynthetic process (GO:0015937) | 2.38616619 |
| 177 | fructose metabolic process (GO:0006000) | 2.38061868 |
| 178 | antibacterial humoral response (GO:0019731) | 2.37909677 |
| 179 | bile acid metabolic process (GO:0008206) | 2.36754171 |
| 180 | glucuronate metabolic process (GO:0019585) | 2.35945605 |
| 181 | uronic acid metabolic process (GO:0006063) | 2.35945605 |
| 182 | L-ascorbic acid metabolic process (GO:0019852) | 2.35191850 |
| 183 | triglyceride homeostasis (GO:0070328) | 2.34026592 |
| 184 | acylglycerol homeostasis (GO:0055090) | 2.34026592 |
| 185 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.33861128 |
| 186 | membrane raft organization (GO:0031579) | 2.33688074 |
| 187 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.32936475 |
| 188 | positive regulation of cholesterol efflux (GO:0010875) | 2.31558534 |
| 189 | regulation of complement activation (GO:0030449) | 2.29437719 |
| 190 | organic acid catabolic process (GO:0016054) | 2.27261812 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 8.55837841 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.16192167 |
| 3 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.90800815 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.70782518 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.69191963 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.17050510 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.84173826 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.75130008 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.70633535 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.69108011 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.58714102 |
| 12 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.56441555 |
| 13 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.42058636 |
| 14 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.39263027 |
| 15 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.38111214 |
| 16 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.28049864 |
| 17 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.20545214 |
| 18 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.14506841 |
| 19 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.14090200 |
| 20 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.02076081 |
| 21 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.99755607 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.93274952 |
| 23 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.92910605 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.90167942 |
| 25 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.83220532 |
| 26 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.80235098 |
| 27 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.75464525 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.69718014 |
| 29 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.66445174 |
| 30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.65822784 |
| 31 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.65284648 |
| 32 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.60676722 |
| 33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58354437 |
| 34 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.57032679 |
| 35 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.54676407 |
| 36 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.51060345 |
| 37 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.49914573 |
| 38 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.48694822 |
| 39 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.48592972 |
| 40 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.48237386 |
| 41 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47765737 |
| 42 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.47509473 |
| 43 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.47243386 |
| 44 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.45904503 |
| 45 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.45345598 |
| 46 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.43563294 |
| 47 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.41157052 |
| 48 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.34773669 |
| 49 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.34016141 |
| 50 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.34001431 |
| 51 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.33145023 |
| 52 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.33034262 |
| 53 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.32816206 |
| 54 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.32357014 |
| 55 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.32171080 |
| 56 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.30152571 |
| 57 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25584893 |
| 58 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.25309941 |
| 59 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.23241541 |
| 60 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.23241541 |
| 61 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.23098068 |
| 62 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.22030810 |
| 63 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.21705715 |
| 64 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.19168101 |
| 65 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17438653 |
| 66 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.16412521 |
| 67 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15025410 |
| 68 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.13956052 |
| 69 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.13956052 |
| 70 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13815807 |
| 71 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.13334244 |
| 72 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.11588747 |
| 73 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.11215009 |
| 74 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.10693968 |
| 75 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.08941154 |
| 76 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.08607809 |
| 77 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.08121391 |
| 78 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.07165807 |
| 79 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.06747519 |
| 80 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.06610816 |
| 81 | CJUN_26792858_Chip-Seq_BT549_Human | 1.05619523 |
| 82 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.02642784 |
| 83 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.01155061 |
| 84 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.00981842 |
| 85 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.00933863 |
| 86 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.00688889 |
| 87 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.00669128 |
| 88 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99570637 |
| 89 | ATF3_27146783_Chip-Seq_COLON_Human | 0.99149385 |
| 90 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.98595729 |
| 91 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.96849736 |
| 92 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.96833840 |
| 93 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.96784592 |
| 94 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95817602 |
| 95 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.95681443 |
| 96 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.95023418 |
| 97 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.94844032 |
| 98 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.94114261 |
| 99 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93023092 |
| 100 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.92399073 |
| 101 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.89735357 |
| 102 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89626931 |
| 103 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.89592390 |
| 104 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.89284066 |
| 105 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.88951227 |
| 106 | P300_27268052_Chip-Seq_Bcells_Human | 0.88581721 |
| 107 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.88460506 |
| 108 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88325320 |
| 109 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.88110717 |
| 110 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.87898091 |
| 111 | * VDR_24763502_ChIP-Seq_THP-1_Human | 0.87823540 |
| 112 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.87741831 |
| 113 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.87315520 |
| 114 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.87021740 |
| 115 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.85618580 |
| 116 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85082614 |
| 117 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.84553493 |
| 118 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84454486 |
| 119 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.84109157 |
| 120 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.83922825 |
| 121 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.83272555 |
| 122 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82795547 |
| 123 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82468013 |
| 124 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.81711431 |
| 125 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.79215602 |
| 126 | MYB_26560356_Chip-Seq_TH2_Human | 0.79189223 |
| 127 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78758375 |
| 128 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.78755028 |
| 129 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.77086669 |
| 130 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.76828345 |
| 131 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.76547723 |
| 132 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.76145588 |
| 133 | MAF_26560356_Chip-Seq_TH1_Human | 0.75667400 |
| 134 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.74867617 |
| 135 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.73626942 |
| 136 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.73034231 |
| 137 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.72805872 |
| 138 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.72564784 |
| 139 | * VDR_24787735_ChIP-Seq_THP-1_Human | 0.71472586 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 3.64240416 |
| 2 | MP0005670_abnormal_white_adipose | 3.61771422 |
| 3 | MP0003724_increased_susceptibility_to | 3.09339810 |
| 4 | MP0005365_abnormal_bile_salt | 2.66241922 |
| 5 | MP0002138_abnormal_hepatobiliary_system | 2.61145443 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 2.58857849 |
| 7 | MP0003191_abnormal_cellular_cholesterol | 2.54739870 |
| 8 | MP0005666_abnormal_adipose_tissue | 2.48958423 |
| 9 | MP0004130_abnormal_muscle_cell | 2.44459241 |
| 10 | MP0005275_abnormal_skin_tensile | 2.38478912 |
| 11 | MP0010234_abnormal_vibrissa_follicle | 2.37269523 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.26398419 |
| 13 | MP0003186_abnormal_redox_activity | 2.15315669 |
| 14 | MP0005085_abnormal_gallbladder_physiolo | 2.10575405 |
| 15 | MP0005360_urolithiasis | 2.01946633 |
| 16 | MP0010155_abnormal_intestine_physiology | 1.96817322 |
| 17 | MP0004185_abnormal_adipocyte_glucose | 1.93997121 |
| 18 | MP0002971_abnormal_brown_adipose | 1.87627964 |
| 19 | MP0009379_abnormal_foot_pigmentation | 1.86282298 |
| 20 | MP0002166_altered_tumor_susceptibility | 1.84162429 |
| 21 | MP0005166_decreased_susceptibility_to | 1.78297870 |
| 22 | MP0001835_abnormal_antigen_presentation | 1.76207632 |
| 23 | MP0003279_aneurysm | 1.75616115 |
| 24 | MP0002118_abnormal_lipid_homeostasis | 1.74664173 |
| 25 | MP0005375_adipose_tissue_phenotype | 1.72976566 |
| 26 | MP0009785_altered_susceptibility_to | 1.69690975 |
| 27 | MP0005165_increased_susceptibility_to | 1.66809811 |
| 28 | MP0003075_altered_response_to | 1.66787008 |
| 29 | MP0008875_abnormal_xenobiotic_pharmacok | 1.61917211 |
| 30 | MP0004019_abnormal_vitamin_homeostasis | 1.61396979 |
| 31 | MP0002876_abnormal_thyroid_physiology | 1.61395026 |
| 32 | MP0005332_abnormal_amino_acid | 1.52753626 |
| 33 | MP0004510_myositis | 1.51296376 |
| 34 | MP0005535_abnormal_body_temperature | 1.49682309 |
| 35 | MP0003183_abnormal_peptide_metabolism | 1.48570259 |
| 36 | MP0002254_reproductive_system_inflammat | 1.48549546 |
| 37 | MP0000685_abnormal_immune_system | 1.47485772 |
| 38 | MP0001853_heart_inflammation | 1.44449430 |
| 39 | MP0000609_abnormal_liver_physiology | 1.43186725 |
| 40 | MP0003436_decreased_susceptibility_to | 1.43029583 |
| 41 | MP0000858_altered_metastatic_potential | 1.42511201 |
| 42 | MP0003806_abnormal_nucleotide_metabolis | 1.42223203 |
| 43 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.41973722 |
| 44 | MP0004264_abnormal_extraembryonic_tissu | 1.39703822 |
| 45 | MP0000372_irregular_coat_pigmentation | 1.38725454 |
| 46 | MP0005334_abnormal_fat_pad | 1.37535236 |
| 47 | MP0005503_abnormal_tendon_morphology | 1.36523778 |
| 48 | MP0001666_abnormal_nutrient_absorption | 1.35878506 |
| 49 | MP0002822_catalepsy | 1.35321456 |
| 50 | MP0000013_abnormal_adipose_tissue | 1.34158266 |
| 51 | MP0003868_abnormal_feces_composition | 1.34023464 |
| 52 | MP0000343_altered_response_to | 1.32605066 |
| 53 | MP0005083_abnormal_biliary_tract | 1.30673981 |
| 54 | MP0002060_abnormal_skin_morphology | 1.29809443 |
| 55 | MP0009115_abnormal_fat_cell | 1.29188411 |
| 56 | MP0001533_abnormal_skeleton_physiology | 1.26643159 |
| 57 | MP0009643_abnormal_urine_homeostasis | 1.26258119 |
| 58 | MP0005257_abnormal_intraocular_pressure | 1.26238346 |
| 59 | MP0002148_abnormal_hypersensitivity_rea | 1.25504967 |
| 60 | MP0001958_emphysema | 1.25368202 |
| 61 | MP0009840_abnormal_foam_cell | 1.25203256 |
| 62 | MP0002006_tumorigenesis | 1.24976187 |
| 63 | MP0009333_abnormal_splenocyte_physiolog | 1.23966348 |
| 64 | MP0003866_abnormal_defecation | 1.23648255 |
| 65 | MP0002452_abnormal_antigen_presenting | 1.20893526 |
| 66 | MP0005025_abnormal_response_to | 1.20299072 |
| 67 | MP0002837_dystrophic_cardiac_calcinosis | 1.20159439 |
| 68 | MP0005023_abnormal_wound_healing | 1.18992098 |
| 69 | MP0005164_abnormal_response_to | 1.18550058 |
| 70 | MP0010386_abnormal_urinary_bladder | 1.17569378 |
| 71 | MP0005319_abnormal_enzyme/_coenzyme | 1.17532704 |
| 72 | MP0002419_abnormal_innate_immunity | 1.16682946 |
| 73 | MP0003656_abnormal_erythrocyte_physiolo | 1.16265404 |
| 74 | MP0000465_gastrointestinal_hemorrhage | 1.16230544 |
| 75 | MP0006036_abnormal_mitochondrial_physio | 1.15705906 |
| 76 | MP0002277_abnormal_respiratory_mucosa | 1.15420976 |
| 77 | MP0003303_peritoneal_inflammation | 1.15016424 |
| 78 | MP0008469_abnormal_protein_level | 1.14372060 |
| 79 | MP0009764_decreased_sensitivity_to | 1.13530828 |
| 80 | MP0003329_amyloid_beta_deposits | 1.12097787 |
| 81 | MP0002970_abnormal_white_adipose | 1.10762254 |
| 82 | MP0005058_abnormal_lysosome_morphology | 1.10672213 |
| 83 | MP0005464_abnormal_platelet_physiology | 1.10352025 |
| 84 | MP0003950_abnormal_plasma_membrane | 1.09957742 |
| 85 | MP0001663_abnormal_digestive_system | 1.09859283 |
| 86 | MP0000003_abnormal_adipose_tissue | 1.06993904 |
| 87 | MP0001873_stomach_inflammation | 1.06476277 |
| 88 | MP0001542_abnormal_bone_strength | 1.05606893 |
| 89 | MP0003195_calcinosis | 1.05544338 |
| 90 | MP0004947_skin_inflammation | 1.04572274 |
| 91 | MP0003705_abnormal_hypodermis_morpholog | 1.04084759 |
| 92 | MP0001756_abnormal_urination | 1.02681546 |
| 93 | MP0008260_abnormal_autophagy | 1.01097289 |
| 94 | MP0005000_abnormal_immune_tolerance | 0.99484728 |
| 95 | MP0003959_abnormal_lean_body | 0.99481321 |
| 96 | MP0004272_abnormal_basement_membrane | 0.99198026 |
| 97 | MP0005671_abnormal_response_to | 0.98236388 |
| 98 | MP0002295_abnormal_pulmonary_circulatio | 0.97068624 |
| 99 | MP0001790_abnormal_immune_system | 0.96416907 |
| 100 | MP0005387_immune_system_phenotype | 0.96416907 |
| 101 | MP0005501_abnormal_skin_physiology | 0.95413716 |
| 102 | MP0003252_abnormal_bile_duct | 0.95017998 |
| 103 | MP0004883_abnormal_blood_vessel | 0.95004880 |
| 104 | MP0003690_abnormal_glial_cell | 0.94946931 |
| 105 | MP0002933_joint_inflammation | 0.94526538 |
| 106 | MP0003453_abnormal_keratinocyte_physiol | 0.93510645 |
| 107 | MP0001764_abnormal_homeostasis | 0.92480247 |
| 108 | MP0009384_cardiac_valve_regurgitation | 0.92259327 |
| 109 | MP0001881_abnormal_mammary_gland | 0.92156026 |
| 110 | MP0002136_abnormal_kidney_physiology | 0.92110399 |
| 111 | MP0001845_abnormal_inflammatory_respons | 0.92068694 |
| 112 | MP0001819_abnormal_immune_cell | 0.92012647 |
| 113 | MP0003011_delayed_dark_adaptation | 0.91603279 |
| 114 | MP0001661_extended_life_span | 0.90861000 |
| 115 | MP0001879_abnormal_lymphatic_vessel | 0.90420756 |
| 116 | MP0003638_abnormal_response/metabolism_ | 0.90082734 |
| 117 | MP0009763_increased_sensitivity_to | 0.89984825 |
| 118 | MP0003315_abnormal_perineum_morphology | 0.89810024 |
| 119 | MP0004381_abnormal_hair_follicle | 0.89340707 |
| 120 | MP0001216_abnormal_epidermal_layer | 0.89296154 |
| 121 | MP0004782_abnormal_surfactant_physiolog | 0.89113564 |
| 122 | MP0002420_abnormal_adaptive_immunity | 0.88999185 |
| 123 | MP0000249_abnormal_blood_vessel | 0.88571617 |
| 124 | MP0002877_abnormal_melanocyte_morpholog | 0.86533666 |
| 125 | MP0003566_abnormal_cell_adhesion | 0.86122068 |
| 126 | MP0002723_abnormal_immune_serum | 0.85500621 |
| 127 | MP0005408_hypopigmentation | 0.85281783 |
| 128 | MP0000490_abnormal_crypts_of | 0.84187826 |
| 129 | MP0002078_abnormal_glucose_homeostasis | 0.83280577 |
| 130 | MP0002638_abnormal_pupillary_reflex | 0.82824086 |
| 131 | MP0001800_abnormal_humoral_immune | 0.82444522 |
| 132 | MP0005381_digestive/alimentary_phenotyp | 0.81934632 |
| 133 | MP0005448_abnormal_energy_balance | 0.81069462 |
| 134 | MP0002998_abnormal_bone_remodeling | 0.81020168 |
| 135 | MP0006082_CNS_inflammation | 0.79466708 |
| 136 | MP0005084_abnormal_gallbladder_morpholo | 0.79389856 |
| 137 | MP0005330_cardiomyopathy | 0.79242838 |
| 138 | MP0003045_fibrosis | 0.78401432 |
| 139 | MP0002796_impaired_skin_barrier | 0.78261829 |
| 140 | MP0000604_amyloidosis | 0.78204032 |
| 141 | MP0005390_skeleton_phenotype | 0.75916209 |
| 142 | MP0010368_abnormal_lymphatic_system | 0.75488725 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypothermia (HP:0002045) | 4.55344293 |
| 2 | Glomerulonephritis (HP:0000099) | 4.30101828 |
| 3 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.86524000 |
| 4 | Malnutrition (HP:0004395) | 3.72826615 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.40911063 |
| 6 | Oligomenorrhea (HP:0000876) | 3.34596870 |
| 7 | Increased muscle lipid content (HP:0009058) | 3.30034715 |
| 8 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.28129413 |
| 9 | Hyperglycinuria (HP:0003108) | 3.25447632 |
| 10 | Hepatic necrosis (HP:0002605) | 3.23519542 |
| 11 | Hypertriglyceridemia (HP:0002155) | 3.14868522 |
| 12 | Complement deficiency (HP:0004431) | 3.11327868 |
| 13 | Acanthosis nigricans (HP:0000956) | 3.07944105 |
| 14 | Dicarboxylic aciduria (HP:0003215) | 3.07681372 |
| 15 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.07681372 |
| 16 | Xanthomatosis (HP:0000991) | 3.06846082 |
| 17 | Abnormality of glycolipid metabolism (HP:0010969) | 2.96024582 |
| 18 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.96024582 |
| 19 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.96024582 |
| 20 | Hypoglycemic coma (HP:0001325) | 2.93395069 |
| 21 | Intrahepatic cholestasis (HP:0001406) | 2.86311438 |
| 22 | Generalized aminoaciduria (HP:0002909) | 2.80194001 |
| 23 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.78029472 |
| 24 | Abnormality of glycine metabolism (HP:0010895) | 2.78029472 |
| 25 | Hyperlipoproteinemia (HP:0010980) | 2.75820266 |
| 26 | Hyperammonemia (HP:0001987) | 2.74717293 |
| 27 | Abnormal hemoglobin (HP:0011902) | 2.73387025 |
| 28 | Distal lower limb muscle weakness (HP:0009053) | 2.71502194 |
| 29 | Abnormality of proline metabolism (HP:0010907) | 2.71281109 |
| 30 | Hydroxyprolinuria (HP:0003080) | 2.71281109 |
| 31 | Hyperactive renin-angiotensin system (HP:0000841) | 2.68200517 |
| 32 | Myoglobinuria (HP:0002913) | 2.67179506 |
| 33 | Systemic lupus erythematosus (HP:0002725) | 2.66710306 |
| 34 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.63729629 |
| 35 | Acute encephalopathy (HP:0006846) | 2.62755000 |
| 36 | Right ventricular cardiomyopathy (HP:0011663) | 2.62230287 |
| 37 | Hepatocellular necrosis (HP:0001404) | 2.61846589 |
| 38 | Cerebral edema (HP:0002181) | 2.61226516 |
| 39 | Alopecia of scalp (HP:0002293) | 2.58054674 |
| 40 | Ketosis (HP:0001946) | 2.54595592 |
| 41 | Growth hormone excess (HP:0000845) | 2.54555067 |
| 42 | Vacuolated lymphocytes (HP:0001922) | 2.53321450 |
| 43 | Abnormality of macrophages (HP:0004311) | 2.52012334 |
| 44 | Neonatal hypoglycemia (HP:0001998) | 2.51508823 |
| 45 | Pustule (HP:0200039) | 2.50272792 |
| 46 | Vascular calcification (HP:0004934) | 2.41815731 |
| 47 | Acute necrotizing encephalopathy (HP:0006965) | 2.38432920 |
| 48 | Pancreatitis (HP:0001733) | 2.38175413 |
| 49 | Delayed CNS myelination (HP:0002188) | 2.38139055 |
| 50 | Abnormality of complement system (HP:0005339) | 2.37618889 |
| 51 | Nausea (HP:0002018) | 2.35340855 |
| 52 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.35242654 |
| 53 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.34224191 |
| 54 | Deep venous thrombosis (HP:0002625) | 2.33542262 |
| 55 | Myocardial infarction (HP:0001658) | 2.32882302 |
| 56 | Prolonged partial thromboplastin time (HP:0003645) | 2.31254012 |
| 57 | Amyloidosis (HP:0011034) | 2.30619727 |
| 58 | Conjugated hyperbilirubinemia (HP:0002908) | 2.30010981 |
| 59 | Rhabdomyolysis (HP:0003201) | 2.29046071 |
| 60 | Bone cyst (HP:0012062) | 2.27914114 |
| 61 | Abnormality of the common coagulation pathway (HP:0010990) | 2.27364075 |
| 62 | Lethargy (HP:0001254) | 2.25707706 |
| 63 | Mitochondrial inheritance (HP:0001427) | 2.22886527 |
| 64 | Thick nail (HP:0001805) | 2.22536066 |
| 65 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.22126161 |
| 66 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.21919810 |
| 67 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.21919810 |
| 68 | Increased intramyocellular lipid droplets (HP:0012240) | 2.21828784 |
| 69 | Hypoalphalipoproteinemia (HP:0003233) | 2.19810182 |
| 70 | Alkalosis (HP:0001948) | 2.19478189 |
| 71 | Purpura (HP:0000979) | 2.17043154 |
| 72 | Axonal loss (HP:0003447) | 2.14744273 |
| 73 | Cardiovascular calcification (HP:0011915) | 2.12372755 |
| 74 | Erythema (HP:0010783) | 2.12294171 |
| 75 | Ketoacidosis (HP:0001993) | 2.11260737 |
| 76 | Renal cortical cysts (HP:0000803) | 2.09810760 |
| 77 | Fat malabsorption (HP:0002630) | 2.07874756 |
| 78 | Recurrent bacterial skin infections (HP:0005406) | 2.05750156 |
| 79 | Ileus (HP:0002595) | 2.04951464 |
| 80 | Progressive macrocephaly (HP:0004481) | 2.04648286 |
| 81 | Lactic acidosis (HP:0003128) | 2.04226922 |
| 82 | Cholecystitis (HP:0001082) | 2.04175548 |
| 83 | Abnormal gallbladder physiology (HP:0012438) | 2.04175548 |
| 84 | Protrusio acetabuli (HP:0003179) | 2.04064674 |
| 85 | Chronic otitis media (HP:0000389) | 2.03552511 |
| 86 | Recurrent abscess formation (HP:0002722) | 2.03386486 |
| 87 | Glucose intolerance (HP:0000833) | 2.03342999 |
| 88 | Abnormal glucose tolerance (HP:0001952) | 2.02732356 |
| 89 | Eczematoid dermatitis (HP:0000976) | 2.02515389 |
| 90 | Interstitial pulmonary disease (HP:0006530) | 2.02434516 |
| 91 | Broad metatarsal (HP:0001783) | 2.01198459 |
| 92 | Vomiting (HP:0002013) | 2.00778461 |
| 93 | Polygenic inheritance (HP:0010982) | 1.99904268 |
| 94 | Conjunctival hamartoma (HP:0100780) | 1.98908132 |
| 95 | Osteolytic defects of the hand bones (HP:0009699) | 1.98486516 |
| 96 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.98486516 |
| 97 | Lipid accumulation in hepatocytes (HP:0006561) | 1.98339700 |
| 98 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.97522821 |
| 99 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.97018660 |
| 100 | Gingivitis (HP:0000230) | 1.96252125 |
| 101 | Vertebral compression fractures (HP:0002953) | 1.95573690 |
| 102 | Premature rupture of membranes (HP:0001788) | 1.95563944 |
| 103 | Abnormal cartilage morphology (HP:0002763) | 1.95315619 |
| 104 | Reduced antithrombin III activity (HP:0001976) | 1.95067795 |
| 105 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.94934090 |
| 106 | Muscle stiffness (HP:0003552) | 1.94745294 |
| 107 | Decreased circulating renin level (HP:0003351) | 1.94546855 |
| 108 | Increased CSF lactate (HP:0002490) | 1.94189471 |
| 109 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.93871762 |
| 110 | Cerebral hemorrhage (HP:0001342) | 1.93859086 |
| 111 | Hypergammaglobulinemia (HP:0010702) | 1.93677464 |
| 112 | Abnormality of the intrinsic pathway (HP:0010989) | 1.90760505 |
| 113 | Prolonged neonatal jaundice (HP:0006579) | 1.90279622 |
| 114 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.89969534 |
| 115 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.89969534 |
| 116 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.89969534 |
| 117 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.89379998 |
| 118 | Beaking of vertebral bodies (HP:0004568) | 1.88967352 |
| 119 | Colitis (HP:0002583) | 1.88451818 |
| 120 | Premature loss of primary teeth (HP:0006323) | 1.88057843 |
| 121 | Loss of speech (HP:0002371) | 1.87947148 |
| 122 | Hyperglycinemia (HP:0002154) | 1.86159639 |
| 123 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.85981687 |
| 124 | Orthostatic hypotension (HP:0001278) | 1.85426983 |
| 125 | Esophageal neoplasm (HP:0100751) | 1.85321151 |
| 126 | Neoplasm of head and neck (HP:0012288) | 1.85321151 |
| 127 | Myositis (HP:0100614) | 1.85317088 |
| 128 | Recurrent bronchitis (HP:0002837) | 1.85042735 |
| 129 | Abnormality of the nasal mucosa (HP:0000433) | 1.84368451 |
| 130 | Aortic aneurysm (HP:0004942) | 1.83415764 |
| 131 | Pulmonary infiltrates (HP:0002113) | 1.83412054 |
| 132 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.82085284 |
| 133 | Mucopolysacchariduria (HP:0008155) | 1.82085284 |
| 134 | Menorrhagia (HP:0000132) | 1.82022017 |
| 135 | Orchitis (HP:0100796) | 1.81314631 |
| 136 | Methylmalonic aciduria (HP:0012120) | 1.79977005 |
| 137 | Petechiae (HP:0000967) | 1.78604662 |
| 138 | Nephritis (HP:0000123) | 1.78087071 |
| 139 | Dysostosis multiplex (HP:0000943) | 1.77843052 |
| 140 | Increased IgE level (HP:0003212) | 1.77059194 |
| 141 | Palmoplantar hyperkeratosis (HP:0000972) | 1.77022060 |
| 142 | Hyperpituitarism (HP:0010514) | 1.75923093 |
| 143 | Brushfield spots (HP:0001088) | 1.75825859 |
| 144 | Respiratory failure (HP:0002878) | 1.74793165 |
| 145 | Tetraparesis (HP:0002273) | 1.73730702 |
| 146 | Cerebral palsy (HP:0100021) | 1.73442360 |
| 147 | Renal Fanconi syndrome (HP:0001994) | 1.73420123 |
| 148 | Skin rash (HP:0000988) | 1.73371504 |
| 149 | Joint hemorrhage (HP:0005261) | 1.73214368 |
| 150 | Impaired platelet aggregation (HP:0003540) | 1.72891178 |
| 151 | Abnormal platelet function (HP:0011869) | 1.72891178 |
| 152 | Metabolic acidosis (HP:0001942) | 1.71786415 |
| 153 | Hemorrhage of the eye (HP:0011885) | 1.71681502 |
| 154 | Multiple enchondromatosis (HP:0005701) | 1.71492279 |
| 155 | Hypobetalipoproteinemia (HP:0003563) | 1.71264447 |
| 156 | Nasal polyposis (HP:0100582) | 1.70490559 |
| 157 | Hypolipoproteinemia (HP:0010981) | 1.70035777 |
| 158 | Abnormality of nucleobase metabolism (HP:0010932) | 1.70026531 |
| 159 | Epidermoid cyst (HP:0200040) | 1.69298489 |
| 160 | Glomerulosclerosis (HP:0000096) | 1.68600395 |
| 161 | Progressive neurologic deterioration (HP:0002344) | 1.67819758 |
| 162 | Increased IgM level (HP:0003496) | 1.66834432 |
| 163 | Mediastinal lymphadenopathy (HP:0100721) | 1.66752070 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA2 | 4.97038823 |
| 2 | BCKDK | 4.10220316 |
| 3 | TESK2 | 3.57248886 |
| 4 | NME2 | 2.98988510 |
| 5 | ERN1 | 2.97543884 |
| 6 | CAMK1D | 2.59952704 |
| 7 | TRIB3 | 2.59312725 |
| 8 | VRK2 | 2.48089327 |
| 9 | SIK1 | 2.17145950 |
| 10 | TBK1 | 2.08082496 |
| 11 | TGFBR2 | 2.06294145 |
| 12 | PIM2 | 2.05488807 |
| 13 | LIMK1 | 2.04988317 |
| 14 | FLT3 | 2.04873717 |
| 15 | KIT | 1.96558746 |
| 16 | MYLK | 1.93031073 |
| 17 | FGFR4 | 1.82629915 |
| 18 | MST1R | 1.73810448 |
| 19 | GRK5 | 1.60314833 |
| 20 | TEC | 1.56353568 |
| 21 | KDR | 1.56318185 |
| 22 | ZAP70 | 1.51842095 |
| 23 | IKBKE | 1.49897989 |
| 24 | TYK2 | 1.49302200 |
| 25 | MST4 | 1.47059949 |
| 26 | JAK3 | 1.45946151 |
| 27 | MAP4K1 | 1.45512985 |
| 28 | MAP3K12 | 1.44009313 |
| 29 | GRK7 | 1.42382428 |
| 30 | MAP2K3 | 1.38012678 |
| 31 | ARAF | 1.37309653 |
| 32 | PDK2 | 1.31928345 |
| 33 | NTRK1 | 1.31311630 |
| 34 | CAMK1G | 1.30488086 |
| 35 | MATK | 1.25193739 |
| 36 | ILK | 1.24782005 |
| 37 | MAP3K14 | 1.24692226 |
| 38 | NEK9 | 1.24539368 |
| 39 | CAMKK2 | 1.18843872 |
| 40 | LRRK2 | 1.18788927 |
| 41 | MAP2K1 | 1.18764542 |
| 42 | PAK4 | 1.18406109 |
| 43 | MAPKAPK5 | 1.17980695 |
| 44 | MAP3K11 | 1.17605105 |
| 45 | JAK1 | 1.15571887 |
| 46 | MAP3K3 | 1.14024386 |
| 47 | PDK3 | 1.11393927 |
| 48 | PDK4 | 1.11393927 |
| 49 | EPHA3 | 1.10444776 |
| 50 | TIE1 | 1.09421989 |
| 51 | EPHB1 | 1.08433877 |
| 52 | TAOK2 | 1.07369923 |
| 53 | MAPKAPK3 | 1.05406655 |
| 54 | CSF1R | 1.04977222 |
| 55 | DAPK1 | 1.03138190 |
| 56 | HIPK2 | 1.00631789 |
| 57 | MAP2K2 | 0.97731349 |
| 58 | TRPM7 | 0.97687657 |
| 59 | PKN2 | 0.97256462 |
| 60 | PTK2 | 0.95537405 |
| 61 | TXK | 0.94406930 |
| 62 | INSRR | 0.94140574 |
| 63 | IRAK3 | 0.92313927 |
| 64 | MAP3K2 | 0.92257786 |
| 65 | TAOK3 | 0.90914471 |
| 66 | PIK3CG | 0.89538900 |
| 67 | LMTK2 | 0.85997661 |
| 68 | PTK6 | 0.85666829 |
| 69 | NLK | 0.84193574 |
| 70 | BTK | 0.83783208 |
| 71 | ITK | 0.83030780 |
| 72 | MAPK15 | 0.82766141 |
| 73 | PRPF4B | 0.82243727 |
| 74 | SIK3 | 0.81060479 |
| 75 | ADRBK2 | 0.80330955 |
| 76 | SYK | 0.79771723 |
| 77 | BMX | 0.79674455 |
| 78 | FGFR3 | 0.78572791 |
| 79 | PTK2B | 0.77760935 |
| 80 | RIPK1 | 0.77627093 |
| 81 | TNK2 | 0.76576168 |
| 82 | IRAK4 | 0.75902120 |
| 83 | PRKAA2 | 0.72532640 |
| 84 | JAK2 | 0.69977526 |
| 85 | LCK | 0.68647537 |
| 86 | SMG1 | 0.68431857 |
| 87 | MAPK4 | 0.67262647 |
| 88 | IKBKB | 0.67041801 |
| 89 | MET | 0.65542460 |
| 90 | STK10 | 0.63548709 |
| 91 | IGF1R | 0.63323676 |
| 92 | ABL2 | 0.62782513 |
| 93 | DAPK3 | 0.60408803 |
| 94 | RIPK4 | 0.60079929 |
| 95 | PRKG2 | 0.59149537 |
| 96 | GRK6 | 0.57925473 |
| 97 | IRAK1 | 0.57216949 |
| 98 | MAPK12 | 0.57185550 |
| 99 | ACVR1B | 0.56772904 |
| 100 | RET | 0.56565821 |
| 101 | MAP3K13 | 0.56175634 |
| 102 | TAOK1 | 0.54716820 |
| 103 | MAPKAPK2 | 0.54380406 |
| 104 | STK16 | 0.54100245 |
| 105 | CDC42BPA | 0.53330617 |
| 106 | PRKCH | 0.52747424 |
| 107 | MAP3K7 | 0.52373016 |
| 108 | PRKCI | 0.51991845 |
| 109 | MUSK | 0.50985937 |
| 110 | TESK1 | 0.49174468 |
| 111 | MAPK11 | 0.48183784 |
| 112 | DDR2 | 0.48141203 |
| 113 | FER | 0.47826536 |
| 114 | DMPK | 0.47517347 |
| 115 | ADRBK1 | 0.46007836 |
| 116 | BLK | 0.45274498 |
| 117 | PDPK1 | 0.44967703 |
| 118 | BMPR2 | 0.44655173 |
| 119 | CSK | 0.43944488 |
| 120 | PIK3CA | 0.43563704 |
| 121 | PRKCQ | 0.43354191 |
| 122 | MAP2K6 | 0.42710150 |
| 123 | TGFBR1 | 0.41701475 |
| 124 | MAP3K1 | 0.41146029 |
| 125 | LYN | 0.40628473 |
| 126 | EPHB2 | 0.40545810 |
| 127 | NME1 | 0.40024024 |
| 128 | PRKD1 | 0.39563483 |
| 129 | MOS | 0.38683952 |
| 130 | SRC | 0.34987418 |
| 131 | OXSR1 | 0.33953340 |
| 132 | PHKG1 | 0.33818225 |
| 133 | PHKG2 | 0.33818225 |
| 134 | PAK1 | 0.32317767 |
| 135 | CAMK2G | 0.31931653 |
| 136 | MAP2K7 | 0.31764640 |
| 137 | MAP3K6 | 0.30156552 |
| 138 | PRKCD | 0.28965218 |
| 139 | STK39 | 0.28416857 |
| 140 | GSK3A | 0.28292425 |
| 141 | MAPK7 | 0.25395582 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.46524588 |
| 2 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.17473591 |
| 3 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.08730275 |
| 4 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.88951184 |
| 5 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.88626844 |
| 6 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.84425896 |
| 7 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.54216898 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.51690368 |
| 9 | Asthma_Homo sapiens_hsa05310 | 2.40704809 |
| 10 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.39608313 |
| 11 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.37036860 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.18994951 |
| 13 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.06502581 |
| 14 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.02646959 |
| 15 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.02086088 |
| 16 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.01222200 |
| 17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.99588294 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 1.96539689 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.81567971 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.71843856 |
| 21 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.70821564 |
| 22 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.69281367 |
| 23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.68954332 |
| 24 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.68447013 |
| 25 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.67185422 |
| 26 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.66778927 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.65791607 |
| 28 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.64609213 |
| 29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.62956935 |
| 30 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.60818073 |
| 31 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.58284028 |
| 32 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.57377306 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.57010497 |
| 34 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.56173044 |
| 35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.53981780 |
| 36 | Galactose metabolism_Homo sapiens_hsa00052 | 1.52313934 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.52209763 |
| 38 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.50888288 |
| 39 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.50778336 |
| 40 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.47723191 |
| 41 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.45120161 |
| 42 | Viral myocarditis_Homo sapiens_hsa05416 | 1.35561825 |
| 43 | Mineral absorption_Homo sapiens_hsa04978 | 1.32731900 |
| 44 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.25658307 |
| 45 | Carbon metabolism_Homo sapiens_hsa01200 | 1.24800525 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.23986748 |
| 47 | Parkinsons disease_Homo sapiens_hsa05012 | 1.23761098 |
| 48 | Influenza A_Homo sapiens_hsa05164 | 1.20163333 |
| 49 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.17037094 |
| 50 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.14843741 |
| 51 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.12432251 |
| 52 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.09710769 |
| 53 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.08015437 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 1.07869145 |
| 55 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.01597429 |
| 56 | Alzheimers disease_Homo sapiens_hsa05010 | 1.01532407 |
| 57 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.95364615 |
| 58 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.94770642 |
| 59 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.94035533 |
| 60 | Ribosome_Homo sapiens_hsa03010 | 0.94009201 |
| 61 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.89421852 |
| 62 | Tuberculosis_Homo sapiens_hsa05152 | 0.89209606 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.88874479 |
| 64 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.87589249 |
| 65 | Protein export_Homo sapiens_hsa03060 | 0.86053895 |
| 66 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84030160 |
| 67 | Retinol metabolism_Homo sapiens_hsa00830 | 0.79685235 |
| 68 | Sulfur relay system_Homo sapiens_hsa04122 | 0.79123910 |
| 69 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.77680490 |
| 70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77422213 |
| 71 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.77230549 |
| 72 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.76626616 |
| 73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.76035008 |
| 74 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.74109636 |
| 75 | ABC transporters_Homo sapiens_hsa02010 | 0.73354631 |
| 76 | Malaria_Homo sapiens_hsa05144 | 0.68722896 |
| 77 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.67874695 |
| 78 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.67659413 |
| 79 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.66391575 |
| 80 | Pertussis_Homo sapiens_hsa05133 | 0.65361766 |
| 81 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.63477276 |
| 82 | Measles_Homo sapiens_hsa05162 | 0.61467997 |
| 83 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.61279617 |
| 84 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.58255096 |
| 85 | Leishmaniasis_Homo sapiens_hsa05140 | 0.57657419 |
| 86 | Prion diseases_Homo sapiens_hsa05020 | 0.57500561 |
| 87 | Lysosome_Homo sapiens_hsa04142 | 0.56738480 |
| 88 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.56308812 |
| 89 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.56237377 |
| 90 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.54885422 |
| 91 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.53913107 |
| 92 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51870119 |
| 93 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.50978215 |
| 94 | Insulin resistance_Homo sapiens_hsa04931 | 0.50420790 |
| 95 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50012860 |
| 96 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.49953753 |
| 97 | Other glycan degradation_Homo sapiens_hsa00511 | 0.45724378 |
| 98 | Huntingtons disease_Homo sapiens_hsa05016 | 0.45565201 |
| 99 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.44854769 |
| 100 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.44559225 |
| 101 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.44529418 |
| 102 | Proteasome_Homo sapiens_hsa03050 | 0.44071635 |
| 103 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.43996100 |
| 104 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.43373638 |
| 105 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.42348954 |
| 106 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.41467256 |
| 107 | Salmonella infection_Homo sapiens_hsa05132 | 0.41427206 |
| 108 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.41148630 |
| 109 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.41030299 |
| 110 | Bile secretion_Homo sapiens_hsa04976 | 0.40649727 |
| 111 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.39565875 |
| 112 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.39245516 |
| 113 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.39157987 |
| 114 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.38427749 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37383498 |
| 116 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.37316955 |
| 117 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.36966398 |
| 118 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.33655987 |
| 119 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.33404735 |
| 120 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.32927034 |
| 121 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.32744411 |
| 122 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.31872451 |
| 123 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.31446868 |
| 124 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.31193848 |
| 125 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.31060734 |
| 126 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.29817728 |
| 127 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.29280638 |
| 128 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.29230475 |
| 129 | Phagosome_Homo sapiens_hsa04145 | 0.28956188 |
| 130 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.28597998 |
| 131 | Amoebiasis_Homo sapiens_hsa05146 | 0.27910417 |
| 132 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.26447103 |
| 133 | Legionellosis_Homo sapiens_hsa05134 | 0.25461105 |

